World Heart Congress | Cardiology Webinar | Cardiology Conferences | Events | Europe

Theme: COVID-19 Challenges for Cardiology

World Heart Congress 2020

World Heart Congress 2020

World Heart Congress 2020 will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Argument on new technology enhancement in the field of Cardiovascular Disease and current practices in cardiovascular therapy, Cardiac progenitor cells, Hypertension for the primary care clinician, Stent procedure, Balloon Valvuloplasty, Coronary thrombectomy, Noninvasive cardiac imaging, Heart failure , Congestive heart failure, Sports Cardiology and more. Differentiating heart disease and other cardiac conditions constitute a team of healthcare professionals, of which the Cardiology technologist is a key player.

Heart Conferences will provide a comprehensive update on all medical, surgical, interventional, and electrophysiological topics in cardiology and also provides the opportunity for clinicians, scientists, doctors and researchers from all over the world to gather and learn the latest advances in the field of cardiology and healthcare and to exchange scientific ideas and experiences in a distinctive environment.

Experts with national and international reputations in various cardio sub-specialties will address the latest guidelines, practice patterns and solutions in cardiovascular medicine. The global cardiology market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. Rising exploration funding majorly driven by Market for cardiology from governments and private investors, increased demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing.

Track 1: Clinical Cardiology

Clinical Cardiology includes studies appertain to cardiac diseases viz., congenital heart diseases, coronary artery disease, heart failure, cardiovascular heart disease, and their epidemiology and pathophysiology of the heart. The therapeutic procedures involving diagnosis and management of cardiac diseases like electrophysiology, cardiovascular devices, cardiac regeneration, cardiac medicine, cardiac surgery, and identification of risk factors for cardiovascular diseases.

Related Conferences: Global Experts Meeting on Frontiers in Heart Congress during April 20-22, 2020 in Tokyo, Japan | 6^th World Heart Congress during May 11-13, 2020 in Tokyo, Japan | 8^th World Heart Congress during May 11-12, 2020 in Munich, Germany | 33^rd World Congress on Cardiology & Heart Diseases during March 27-28, 2020 in Prague, Czech Republic | 5^th International Heart Conference during April 24-25, 2020 in Tokyo, Japan | World Congress of Cardiology during 28-30 March 2020 in Chicago, USA | 6^th World Heart Congress during March 26-27, 2020 in Yokohama, Japan | Scholars World Heart Summit during 18-19 Nov 2019 in Tokyo, Japan | Heart Failure 2020 during May 23-26, 2020 in Barcelona, Spain | 2^nd European Heart Congress during Oct 22-23, 2020 in Rome, Italy.

Track 2: Heart Diseases

Heart disease describes a range of conditions that affect the heart. Diseases under the heart disease includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is often used interchangeably with the cardiovascular disease. It generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart failure, chest pain (angina) or stroke. Other heart conditions, such as those that affect your heart's muscle, valves or rhythm, also are considered forms of heart disease. Many forms of heart disease can be prevented or treated with healthy lifestyle choices.

Track 3: Heart Failure

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently. Not all conditions that lead to heart failure can be reversed, but treatments can improve the signs and symptoms of heart failure and help you live longer. Lifestyle changes such as exercising, reducing salt in your diet, managing stress and losing weight can improve your quality of life. One way to prevent heart failure is to control conditions that cause heart failure, such as coronary artery disease, high blood pressure, diabetes or obesity.

Track 4: Cardiovascular Medicine

Cardiovascular Medicine is the most comprehensive provider of cardiovascular services specializing in the prevention, detection, management and treatment of adult cardiovascular diseases. It is a platform for postgraduate education and scientific work in the fields of cardiology, angiology, hypertension and cardiac and vascular surgery.

Track 5: Cardiac Surgery

Innovative advancements and researches are being made in cardiac surgery every day. The world's all advanced technology and most experienced cardiovascular surgeons and cardiologists are welcome here. Cardiovascular surgeries are those which performed on the heart and circulatory system including the major veins and arteries. Cardiovascular procedures performed by cardiac surgeons.

Track 6: Hypertension

High blood pressure is a serious cardiac disease. The pressure of the blood being pumped through the arteries is higher during hypertension It often has no warning signs or symptoms Over time, the constant pressure overload causes accumulating damage that eventually becomes more than circulatory system can handle, often leading to serious health problems Treating high blood pressure take a pronged approach including, medication, exercise and diet changes.

Track 7: Arrhythmias

An arrhythmia is a problem with the rate or rhythm of your heartbeat. It means that your heart beats too quickly, too slowly, or with an irregular pattern. When the heart beats faster than normal, it is called tachycardia. When the heart beats too slowly, it is called bradycardia. The most common type of arrhythmia is atrial fibrillation, which causes an irregular and fast heartbeat. Many factors can affect your heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias.

Track 8: Cardiac Electrophysiology

The cardiac electrophysiology study(EPS) typically measures the response of the injured or cardiomyopathic myocardium to programmed electrical stimulation on specific pharmacological regimens in order to assess the likelihood that the regimen will successfully prevent potentially fatal sustained ventricular tachycardia or ventricular fibrillation in the future. Such studies may also be conducted in the presence of a newly implanted or newly replaced cardiac pacemaker or automatic implantable cardioverter-defibrillators

Track 9: Pediatric Cardiology

Pediatric Cardiology is also called Pediatric Cardiopulmonary disease which involves the childhood disorder includes both the heart and lungs problems. Pediatric cardiologist is a pediatrician who has gotten broad preparing in diagnosis and treatment of kids' cardiovascular issues. Assessment and treatment may start with the embryo since heart issues can now be identified before birth.

Track 10: Nuclear Cardiology & Cardiac CT

Nuclear Cardiology has played a pivotal role in establishing the diagnosis of heart disease and in the assessment of disease extent and the prediction of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use noninvasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used.

A computed tomography scan is commonly called a CT scan or CAT scan is a test that uses X-rays to view specific areas of your body. These scans use safe amounts of radiation to create detailed images of the body, which can help the doctor to detect any problems. A heart, or cardiac, CT scan is used to view your heart and blood vessels. A heart CT scan may also be called a coronary CT angiogram if it’s meant to view the arteries that bring blood to your heart. The test may be called a coronary calcium scan if it’s meant to determine whether there is a buildup of calcium in your heart.

Track 11: Molecular and Cellular Cardiology

Molecular and Cellular Cardiology is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention and treatment of cardiovascular disease. As an emerging discipline, it has changed conceptual thinking of cardiovascular development, disease etiology and pathophysiology and advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function.

Track 12: Cardiac Nursing and Healthcare

Cardiac nursing is a nursing specialty which deals with the patients who suffer from various conditions of the cardiovascular system. Cardiovascular nurses handle the people with heart diseases and interact with their patients’ families. They may monitor and treat acutely ill patients, or they may focus on cardiac rehabilitation helping patients make lifestyle changes to prevent the worsening of their disease.

Track 13: Cardiac Regeneration

Cardiac Regeneration is a broad effort and comes into existence when the cardiac tissue is damaged and failed to regenerate the myocardium. Where the main principle behind cardiac regeneration is Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate. Current therapies includes such as adult stem and precursor cells, nuclear dynamics of the heart growth, Reprogramming Fibroblasts to Cardiomyocytes, Stem cells and cell therapy.

Track 14: Cardiovascular Engineering

Cardiovascular Engineering is a wide spectrum of research, from basic to transitive in all attributes of cardiovascular physiology and medical treatment. The distribution of research that utilizes engineering principles and methods to enhance basic knowledge and technological solutions related to cardiovascular system. Coverage ranges from subcellular to systems level topics, including other implantable medical devices such as hemodynamics, tissue biomechanics, functional imaging, surgical devices, electrical physiology, tissue engineering and regenerative methods, diagnostic tools, transmission and delivery of biologics and biosensors.

Track 15: Cardiovascular Toxicology and Pharmacology

Cardiovascular pharmacology is the main study of the effects of drugs on the entire cardiovascular system, which includes the heart and blood vessels. Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs

Track 16: Percutaneous Coronary Interventions

Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed. When coronary artery disease causes chest pain or a heart attack, percutaneous coronary interventions, such as angioplasty alone or with a stent, can restore blood flow to your heart.

Track 17: Devices / CRT / ICD / Surgery

Implantable devices have been used for decades to treat heart disease. The first pacemaker was implanted over 40 years ago, and implantable defibrillators were first used in the early 1980s. But the last few years have witnessed a surge in both the types of devices being tested for heart-failure treatment, and in the optimism of experts about their usefulness.

An implantable cardioverter defibrillator (ICD) is a microcomputer that is implanted under the skin of your upper chest area. It is small enough to fit in the palm of your hand. It monitors your heart rate and delivers therapy in the form of small electrical pulses. A cardiac resynchronization therapy implantable cardioverter defibrillator (CRT-D) is a type of specialized ICD used to treat heart failure. Getting a cardiac resynchronization therapy (CRT) heart device is not an open-heart procedure. Before surgery, medication is usually given to make you sleepy and comfortable. The procedure is performed under local anesthesia.

Track 18: Clinical Cases reports in Cardiology

Cardiology case reports give an appropriate assemblage for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are reinforced. Furthermore, studying diagnostic methods from medical cases and interpretation of symptoms is significant to train and increase the processes which are being used in the clinical field

Young Researchers Forum - Young Scientist Awards {World heart Congress 2020}

Prestigious Award for Young Research’s at [World Heart Congress 2020] - Discovering New Exploration in {Cardiology} field

{Heart} Conference Committee is glad to announce “9^th World Heart Congress” webinar during July 29-30, 2020 by focus on the theme: “COVID-19 Challenges for Cardiology”

[World Heart Congress 2020] developments are maintaining their momentum. Cardiology Conference program delves into strategic discussions.

[World Heart Congress 2020] Young Scientist Awards:

{Heart} Conference Committee is intended to honour prestigious award for talented Young researchers, scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of {Cardiology}.

Young Research’s Awards at [World Heart Congress 2020] for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the [World Heart Congress 2020] young research forum.

Benefits:

Young Scientist Award recongination certificate and memento to the winners
Our conferences provide best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development.
Provide an opportunity for research interaction and established senior investigators across the globe in the field
Share the ideas with both eminent researchers and mentors.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Eligibility

Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty with a minimum of 5 years of research experience
Presentation must be into scientific sessions of the conference.
Each Young Researcher / Young Scientist can submit only one paper (as first author or co-author).
Age limit- Under 35yrs
All submissions must be in English.

[World Heart Congress 2020] provides best platform to expand your network, where you can meet scientists, authorities and CROs from around the world. It’s your time to grab the opportunity to join [World Heart Congress 2020] for promoting your research article and to facilitate prestigious award in all categories. In this fame, we look forward for your contribution and astonishing dedication to make our [World Heart Congress 2020] more successful.

Till December 30 – $399 [You can keep your Present YRF Registration Prices]

Till January 30 – $499 [You can keep your Present YRF Registration Prices]

Till February 28 – $599 [You can keep your Present YRF Registration Prices]

Market Analysis:

Aim of this 9^th World Heart Congress is to ensure clinically appropriate cost effective care for your members with heart disease. It arises mainly because of ischemic heart disease, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension and others. The main cause for this disorder includes unhealthy dietary habits, obesity, smoking, high cholesterol, lack of physical activity, excessive alcohol and poor lifestyle. Cardiovascular Diseases is accountable for approximately 15 million deaths each year across the globe and it also states that it is a major cause of death in adults approx. to 50%. A committed forum for the increasing, execution and exchange of information about Cardiovascular Medicine and its areas can be brought up by National/International symposiums, Organizing Conferences and Workshops.

Aetiology, clinical characteristics and therapy:

The aetiology of Heart Failure was hypertension in 45% of the patients while cardiomyopathies were behind 28%, rheumatic heart disease 12%, Ischemic heart disease 9% and other reasons (probable tuberculosis or HIV-related cardiomyopathies, endomyocardial fibrosis and obstructive lung disease) in 6%. is Among those with cardiomyopathies, Heart Failure due to idiopathic dilated cardiomyopathy was most frequent (81%), followed by postpartum cardiomyopathy (15%) while hypertrophic and restrictive cardiomyopathies were rare (5%). Rheumatic mitral disease with regurgitation was the most prevalent valvular lesion (81%), followed by mitral stenosis (15%) and aortic regurgitation (3%).

Importance and Scope: -

World Cardiology Meeting will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.

Growth of Cardiology Market: -

North America is the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2018, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.

Statistics of Physicians, Researchers and Academicians working on Cardiology Research

The main part of the world associated with Cardiology field are Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students and Writers of Pediatric Cardiology Department as well as Founders and Employees of the related companies, Associations members, related organizations, laboratories members etc.

The important goal of heart-failure therapy is to inhibit the progression of congestive heart failure through pharmacological, device-based therapies. Therefore, there have been efforts to develop device-based therapies aimed at improving cardiac reserve and optimizing pump function to meet metabolic requirements. The course of congestive heart failure is often worsened by other conditions, including new-onset arrhythmias, ischemia and infarction, valvulopathy, decompensation, end-organ damage, and therapeutic refractoriness, that have an impact on outcomes. The onset of such conditions is sometimes heralded by subtle pathophysiologic changes, and the timely identification of these changes may promote the use of preventive measures. Consequently, device-based methods could in the future have an important role in the timely identification of the subtle pathophysiologic changes associated with congestive heart failure.

Target Audience:

Cardiologists
Professors, Associate Professors
Heart Societies & Associations
Cardio-thoracic Surgeons
Cardiac Surgeons
Research Scholars
Cardiology Fellows
Research Institutes
Vascular Biologists
Manufacturing
Associations and Societies of Cardiology
Training Institutes
Cardiology Students, Scientists
Cardiology and Cardiac Nursing Associations
Graduates and Post Graduates
Directors, CEO’s of Organizations
Medicine Experts

Related Companies/Industries:

MEDNAX, Inc
AstraZeneca
Sanofi
Boehringer Ingelheim
Roche
Bristol-Myers Squibb
United Therapeutics
Astellas
Actelion
Sanofi
Takeda
Otsuka
Gilead Sciences
Johnson & Johnson

Related Universities:

Europe:

University Maastricht/Academic Hospital Maastricht
Medical University of Graz
University of Debrecen Medical School
University of Nicosia Medical School
Imperial College London
Johns Hopkins University
Bukovinian State Medical University
Heidelberg University
Hamburg University
University of Lodz

World Wide:

Vanderbilt University
Cornell University
University of Washington
University of Michigan
Harvard University
University of Texas South-western Medical Centre
University of Alabama-Birmingham
Emory University
Yale University
North-western University
Vanderbilt University
University of Rochester

Related Societies & Associations:

USA:

American Cardiology Association
American College of Cardiology
Association of Cardiologists
American Heart Association- AHA
American Society of Hypertension
Brazilian Society of Cardiology
Heart & Stroke Foundation of Barbados
Argentina Heart Foundation
Argentina Society of Cardiology
Argentina Federation of Cardiology
Canadian Cardiovascular society
The American Society for Preventive Cardiology
American Society of Nuclear Cardiology
American Stroke Association
Society for Cardiovascular Angiography and Interventions
Arizona Society of Echocardiography
Heart Failure Society of America
Canadian Association of Cardiovascular Prevention and Rehabilitation
Elsevier Society Partners in Cardiology
American Society for Preventive Cardiology
American Society of Echocardiography
American Society of Hypertension
Brazilian Society of Hypertension
Canadian Association of Interventional Cardiology
The American Association of Cardiovascular and Pulmonary Rehabilitation
The Society for Cardiovascular Angiography and Interventions Foundation
American Association for Thoracic Surgery
Congenital Cardiac Anaesthesia Society
Northwest Association of Cardiovascular and Pulmonary Rehabilitation
The Society for Cardiovascular Angiography and Interventions Foundation
Vascular and Endovascular Surgery Society
Canadian Association of Interventional Cardiology
Latin American Society of Hypertension
Congenital Heart Surgeon's Society
The Society for Cardiovascular Angiography and Interventions
The Society of Invasive Cardiovascular Professionals
The Society of Thoracic Surgeons
International Society for Applied Cardiovascular Biology

Europe:

World Heart Federation
European Society of Cardiology
World Heart Failure Society
Belgian Society of Cardiology
Austrian Society of Cardiology
British Cardiovascular Society
British Association for Cardiovascular Prevention and Rehabilitation
Philippine Heart Association
Swiss Society of Cardiology
Association of European Pediatric and Congenital Cardiology
Belorussian Scientific Society of Cardiologists
British Hypertension Society
Moldavian Society of Cardiology
Association of Cardiologists of Bosnia & Herzegovina
Austrian Heart Foundation
Austrian Society of Cardiology
Hellenic Cardiology Society
Estonian Society of Cardiology
Society for Cardiology Science & Technology
The Finnish Cardiac Society
British Congenital Cardiac Association
Spanish Society of Cardiology
Uruguayan Society of Cardiology
German Cardiac Society
Luxembourg Society of Cardiology
British Junior Cardiologists Association
The Egyptian Society of Cardiology
The Hungarian Society of Cardiology
European Association for Cardio-Thoracic Surgery
Heart Valve Society
Italian Society of Cardiology
Portuguese Society of Cardiology
Kyrgyz Society of Cardiology
Norwegian Society of Cardiology
Slovenian Society of Cardiology
Hellenic Cardiovascular Research Society
Icelandic Heart Association
Netherlands Society of Cardiology
Irish Cardiac Society
European Association of Cardiothoracic Anaesthesiologists
Belorussian Scientific Society of Cardiologists

Asia pacific:

Asian Pacific Society of Hypertension
Asia Pacific Hearth Rhythm Society
Association of Cardiologists of Kazakhstan
National Center of Cardiology and Therapy
Cyprus Society of Cardiology
Algerian Society of Hypertension
Russian Society of Cardiology
Armenian Cardiologists Association
Saudi Heart Association
Turkish Society of Cardiology
Emirates Cardiac Society
Egyptian Cardiology Society
Iranian Heart Association
Asian Pacific Society of Cardiology
Cardiac Society of Australia & New Zealand
The Japanese Heart Failure Society
Japanese Society of Echocardiography
The World Society of Cardiovascular & Thoracic Surgeons
Asian Pacific Society of Hypertension
Association of Cardiologists of Kazakhstan
Australian Cardiovascular Health and Rehabilitation Association
Association of Thoracic and Cardiovascular Surgeons of Asia
Chinese Society of Cardiology
The Pan-African Society of Cardiology
Association of Pediatric Cardiology
Cardiology Society of India
Asian Society of Cardiovascular Imaging
Association of Black Cardiologists
Interventional Cardiovascular Society of Malaysia
Israeli Cardiology and Critical Care Nursing Society
Japanese Society of Thoracic Radiology
Korean Society for Thoracic and Cardiovascular Surgery
Kyrgyz Society of Cardiology
Lebanese Society of Cardiology
The Heart foundation of Malaysia
The Japanese Society of Hypertension

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 29-30, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View